Hepatitis B prevalence and risk factors in Morocco;Prévalence de l'infection par le virus de l'hépatite B et l'évaluation des facteurs de risque au Maroc

Pathologie Biologie

Volumn 60, Issue 5, 2012, Pages

  Sbai, A ^a   Baha, W ^b   Ougabrai, H ^b   Allalia, T ^b   Dersi, N ^b   Lazaar, F ^b   Ennaji, M M ^b   Benjouad, A ^c   El Malki, A ^b   Hassar, M ^b   Benani, A ^b  

^a FACULTÉ DES SCIENCES   (Morocco)

^b Institut Pasteur du Maroc   (Morocco)

^c NATIONAL CENTER FOR SCIENTIFIC AND TECHNICAL RESEARCH   (Morocco)

Author keywords

Epidemiology; Hepatitis B; Prevalence; Prevention; Risk factors

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MOROCCO; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SCREENING TEST; SEXUAL BEHAVIOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; MALE; MIDDLE AGED; MOROCCO; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84867490520     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2011.06.001     Document Type: Article

References (33)

1. Muszlak M., Lartigau-Roussin C., Farthouat L., Petinelli M., Hebert J.C., Santiago J. Vaccination de l'enfant contre l'hépatite B à Mayotte, île française des Comores. Arch Pediatr 2007, 14:1132-1136.
2. Pierre Tiollais M., Chen Zhu M. The hepatitis B. Pathol Biol 2010, 58:243-244.
3. Bristol-Myers S. Hépatite B : mieux la connaître pour mieux la traiter. J Pediatr Pueric 2006, 19:340-343.
4. Hou J., Liu Z., Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005, 2:50-57.
5. Rizzetto M., Ciancio A. Chronic HBV-related liver disease. Mol Aspects Med 2008, 29:72-84.
6. Read J.S., Cannon M.J., Stanberry L.R., Schuval S. Prevention of mother-to-child transmission of viral infections. Curr Probl Pediatr Adolesc Health Care 2008, 38:274-297.
7. OMS Genève. Introduction du vaccin contre l'hépatite B dans les services de vaccination infantile. WHO/V&B/01.31. 2002 Available from: http://www.who.int/vaccines-documents/.
8. Michel M.L., Tiollais P. Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathol Biol 2010, 58:288-295.
9. Alter Miriam J. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006, 44:6-9.
10. André F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000, 18:20-22.
11. Barkat A, Braikat M, Lamdouar Bouazzaoui N. Calendrier national de vaccination : évolution et perspectives. Available from: http://www.santemaghreb.com/.
12. Ben Amora I., Rekika T., Hentatia N., Fkib H., Kharrata F., Gargouria J. Facteurs influençant la prévalence de l'antigène HB chez des donneurs de sang tunisiens. étude à propos de 275300 donneurs de sang. Transfus Clin Biol 2009, 16:283-349.
13. Khelifa F., Thibault V. Caractéristiques des souches virales responsables d'hépatites B chroniques en Algérie du Nord-Est. Pathol Biol 2009, 57:107-113.
14. Romanò L., Paladini S., Tagliacarne C., Zappa A., Zanetti Z.A. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination. Vaccine 2009, 27:3439-3442.
15. Odusanya O.O., Meurice F.P., Hoet B. Nigerian medical students are at risk for hepatitis B infection. Trans R Soc Trop Med H 2007, 101:465-468.
16. Siegel D., Alter M.J., Morse S. Hepatitis B virus infection in high-risk inner-city neighborhoods in San Francisco. Hepatology 1995, 22:44-49.
17. Chakravarty R., Chowdhury A., Chaudhuri S., Santra A., Neogi M., Rajendran K., et al. Hepatitis B infection in Eastern Indian families: need for screening of adult siblings and mothers of adult index cases. Public Health 2005, 119:647-654.
18. Dumpis U., Charles Holmes E., Mendy M., Hill A., Thursz M., Hall A., et al. Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol 2001, 35:99-104.
19. Kao J.H., Chen D.S. Global control of hepatitis B virus infection. Lancet Infect Dis 2002, 2:395-403.
20. Roggendorf M., Viazov S. Health care workers and hepatitis B. J Hepatol 2003, 39:89-92.
21. André A. Teenagers' lifestyle and the risk of exposure to hepatitis B virus. Vaccine 2000, 18:26-29.
22. Van der Eijk A., Niesters H.G.M., Götz H.M., Janssen H.L.A., Schalm S.W., Osterhaus A.D.M.E., et al. Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent. J Clin Virol 2004, 29:92-94.
23. Yang J., Luo Q., Zhang C., Wang H. Study on HBV vertical transmission via the in vitro fertilization (IVF) technique. J Reprod Contracept 2009, 20:73-79.
24. Kidd-Ljunggren K., Holmberg A., Bläckberg J., Lindqvist B. High levels of hepatitis B virus DNA in body fluids from chronic carriers. J Hosp Infect 2006, 64:352-357.
25. de Oliveira P.R., Yamamoto A.Y., de Souza C.B.S., de Araújo N.M., de Andrade Gomes S., Heck A.R., et al. Hepatitis B viral markers in banked human milk before and after Holder pasteurization. J Clin Virol 2009, 45:281-284.
26. Niederhausera C., Mansouri Taleghania B., Graziania M. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?. Swiss Med Wkly 2008, 138:134-141.
27. Almeida R.P.A., Cardoso D.D.D.P. Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor. J Clin Virol 2006, 36:231-234.
28. Busch M.P. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?. Transfus Clin Biol 2004, 11:26-32.
29. Liu C.J., Chen D.S., Chen P.J. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006, 36:33-44.
30. Mast E.E., Alter M.J., Margolis H.S. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999, 17:1730-1733.
31. Wu P.C., Margaret B., Comfort M.B., Lin H.J. Epidemiological study of hepatitis B virus infection in a dental outpatient population. J Hong Kong Med Assoc 1989, 41:351-354.
32. Arboleda M., Castilho M.C., Fonseca J.C.F., Albuquerque B.C., Saboia R.C., Yoshida C.F.T. Epidemiological aspects of hepatitis B and D virus infection in the northern region of Amazonas, Brazil. Trans R Soc Trop Med H 1995, 89:481-483.
33. Sbai A., Bennani A., Benjouad A., Hassar M. HBV genotypes in Morocco. J Clin Virol 2007, 38:184-185.